Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Anti-CD20 therapy reduces lesi...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Anti-CD20 therapy reduces lesion volume and activated microglia in rodent models of multiple sclerosis
Bibliographic Details
Main Authors:
Seneca, N
,
Campbell, S
,
Balazs, M
,
Leppert, D
,
Anthony, D
Format:
Conference item
Published:
2012
Holdings
Description
Similar Items
Staff View
Similar Items
Anti-CD20 Therapy Reduces Microglial Activation and Lesion Volume in Focal Models of Pattern I and Pattern II Multiple Sclerosis
by: Leppert, D, et al.
Published: (2012)
Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis
by: Anthony, D, et al.
Published: (2012)
Anti-CD20 therapy down-regulates lesion formation and microglial activation in pattern I and pattern II rat models of multiple sclerosis
by: Anthony, D, et al.
Published: (2014)
Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
by: Anthony, D, et al.
Published: (2014)
Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation
by: Aletta M. R. van den Bosch, et al.
Published: (2024-02-01)